Vol 50, No 3 (2012)
Original paper
Published online: 2012-10-08

open access

Page views 2207
Article views/downloads 2120
Get Citation

Connect on Social Media

Connect on Social Media

Complement inhibitory proteins expression in placentas of thrombophilic women

Przemysław Krzysztof Wirstlein, Piotr Jasiński, Marcin Rajewski, Tomasz Goździewicz, Jana Skrzypczak
DOI: 10.5603/FHC.2012.0064
Folia Histochem Cytobiol 2012;50(3):460-467.

Abstract

Factors controlling complement activation appear to exert a protective effect on pregnancy. This is
particularly important in women with thrombophilia. The aim of this study was to determine the transcript and
protein levels of complement decay-accelerating factor (DAF) and membrane cofactor protein (MCP) in the
placentas of women with acquired and inherited thrombophilia. Also, we assessed immunohistochemistry staining
of inhibitors of the complement cascade, DAF and MCP proteins, in the placentas of thrombophilic women.
Placentas were collected from eight women with inherited thrombophilia and ten with acquired thrombophilia.
The levels of DAF and MCP transcripts were evaluated by qPCR, the protein level was evaluated by Western
blot. We observed a higher transcript (p < 0.05) and protein (p < 0.001) levels of DAF and MCP in the placentas
of thrombophilic women than in the control group. DAF and MCP were localized on villous syncytiotrophoblast
membranes, but the assessment of staining in all groups did not differ. The observed higher expression level of
proteins that control activation of complement control proteins is only seemingly contradictory to the changes
observed for example in the antiphospholipid syndrome. However, given the hitherto known biochemical changes
associated with thrombophilia, a mechanism in which increased expression of DAF and MCP in the placentas is
an effect of proinflammatory cytokines, which accompanies thrombophilia, is probable.

Article available in PDF format

View PDF Download PDF file